TNFSF11 and rheumatoid arthritis: The anti-human RANKL monoclonal antibody denosumab improved BMD and bone strength in ovariectomized cynomolgus monkeys [50] and inhibited bone erosion progression compared with placebo in clinical trials for RA [51].